Location History:
- Oceanside, CA (US) (2017 - 2023)
- Fullerton, CA (US) (2019 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: The Innovative Contributions of Marc Lim
Introduction
Marc Lim is a prominent inventor based in Oceanside, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work at Ionis Pharmaceuticals, Inc. With a total of six patents to his name, Lim has focused on developing advanced compositions that address critical health issues.
Latest Patents
Among his latest patents, Lim has developed antisense oligonucleotide compositions. These compositions comprise an antisense oligonucleotide and one or more excipients that modulate viscosity, turbidity, or both. In certain embodiments, he has provided compositions with low viscosity and low turbidity, which are essential for pharmaceutical applications. Additionally, Lim has disclosed methods and compositions for modulating apolipoprotein (a) expression. These antisense compounds aim to decrease apo(a) levels to treat, prevent, or ameliorate diseases related to apo(a) or Lp(a), including inflammatory, cardiovascular, and metabolic disorders.
Career Highlights
Marc Lim's career at Ionis Pharmaceuticals, Inc. has been marked by his dedication to advancing medical science through innovative research. His work has not only contributed to the understanding of antisense technology but has also paved the way for new therapeutic approaches to complex health conditions.
Collaborations
Lim collaborates with notable colleagues, including Andrew Dibble and Rosanne M. Crooke. Their combined expertise enhances the research and development efforts at Ionis Pharmaceuticals, fostering an environment of innovation and discovery.
Conclusion
Marc Lim's contributions to the field of pharmaceuticals through his patents and collaborative efforts exemplify the impact of innovation in addressing critical health challenges. His work continues to inspire advancements in medical science and therapeutic development.